Amid an ongoing review to reschedule cannabis to a low-risk drug category, some officials within the U.S. Drug Enforcement Administration (DEA) have raised concerns over such a move, The Wall Street ...
Source LinkAmid an ongoing review to reschedule cannabis to a low-risk drug category, some officials within the U.S. Drug Enforcement Administration (DEA) have raised concerns over such a move, The Wall Street ...
Source Link
Comments